PLEXIUM
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases. Plexium's platform focuses on the discovery of next-generation TPD drugs that extend beyond the limited applications of Proteolysis Targeting Chimeras (PROTACs) and cereblon imids, unraveling the boundless possibilities of true drug-like protein degraders. From molecular glues to monovalent degraders, the possibilities are endless across a wide variety of therapeutic areas.
PLEXIUM
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.plexium.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
165 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics LetsEncrypt
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Capital Rx
Capital Rx is a healthtech platform that provides pharmacy benefit management solutions.
Castor
Castor offers a cloud-based clinical data platform that simplifies and streamlines clinical trials processes.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
H1.co
H1 provides a health data platform to support the end-to-end therapeutic development process of medical companies and healthcare systems.
Ophelia
Ophelia offers medication and support for quitting opioids.
Traya Health
Traya Health offers a treatment platform that targets hair loss through a combination of Ayurvedic medicine, nutrition and allopathy.
Current Advisors List
Current Employees Featured
Founder
Investors List
CRV
CRV investment in Series B - Plexium
RA Capital Management
RA Capital Management investment in Series B - Plexium
Pappas Capital
Pappas Capital investment in Series B - Plexium
DCVC Bio
DCVC Bio investment in Series B - Plexium
SoftBank Vision Fund
SoftBank Vision Fund investment in Series B - Plexium
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series B - Plexium
M Ventures
M Ventures investment in Series B - Plexium
Surveyor Capital
Surveyor Capital investment in Series B - Plexium
Lux Capital
Lux Capital investment in Series B - Plexium
Neotribe Ventures
Neotribe Ventures investment in Series B - Plexium
Key Employee Changes
Official Site Inspections
http://www.plexium.com Semrush global rank: 4.26 M Semrush visits lastest month: 2.31 K
- Host name: 199.16.173.125
- IP address: 199.16.173.125
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Plexium"
Plexium | Startup Profile and Investments - Bounce Watch
Plexium is a next-generation targeted protein degradation startup that was founded in 2018. Positioned as the premier company in this field, Plexium aims to discover a wide range of โฆSee details»
Plexium, Inc. Company Profile | San Diego, CA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Plexium, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Team Archive - Plexium, Inc.
Mar 31, 2025 Plexium Announces Multiple Presentations at AACR 2025 with Selective Monovalent Degrader Programs Targeting SMARCA2, IKZF2 and CDK2 News April 2, 2025See details»
Plexium - BIO International Convention 2025
Plexium is the premier, next-generation Targeted Protein Degradation (TPD) company seeking to discover a wide range of monovalent degraders that address the limitations of first-generation โฆSee details»
Plexium - Transformative Precision Medicines for โฆ
Plexium harnesses a differentiated platform of proprietary technologies and approaches to establish a robust and diverse portfolio.See details»
Plexium CEO and Key Executive Team - Craft.co
Plexium's Executive Chairman is Mike Grey. Other executives include Kevin Eastwood, Executive Vice President, Corporate Business Development; Simon Bailey, Executive Vice President, โฆSee details»
Plexium - Tech Company Profile - Gaebler.com Venture Capital โฆ
Plexium is a drug development startup that leverages techniques from various physical-science and computational disciplines. The company develops 'molecular glues' that alter E3-ligase โฆSee details»
Plexium Appoints Percival Barretto-Ko as President and Chief โฆ
San Diego, Calif., November 4, 2021 โ Plexium Inc., (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the appointment of experienced โฆSee details»
Plexium Reviews: Pros And Cons of Working At Plexium
Jan 19, 2021 9 Plexium reviews. A free inside look at company reviews and salaries posted anonymously by employees.See details»
Plexium cuts staff, realigns resources to support pipeline
Jun 3, 2025 Protein degradation company Plexium has laid off staff as part of a realignment to support the companyโs pipeline, which is mostly preclinical, Fierce Biotech has learned. โฆSee details»
Plexium Org Chart + Executive Team - The Official Board
The org chart of Plexium contains its 16 main executives including Michael Martin and Stephen Mullennix.See details»
Plexium - Crunchbase Company Profile & Funding
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.See details»
Stephen Mullennix - Chief Financial Officer - Plexium, Inc.
Stephen joined Plexium from ProSciento, Inc., a leading Clinical Research Organization in the metabolic disease arena, where he served as CFO. Prior to ProSciento, Mr. Mullennix was โฆSee details»
Plexium - LifeScienceHistory.com
Plexium is the premier, next-generation targeted protein degradation company, seeking to discover a wide range of monovalent target protein degraders that address the limitations of โฆSee details»
Plexium Inc - Company Profile and News - Bloomberg Markets
Jul 6, 2017 Company profile page for Plexium Inc including stock price, company news, executives, board members, and contact informationSee details»
Plexium CEO, Founder, Key Executive Team, Board of Directors
Explore {Plexium's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Mission, Vision & Core Values of Plexium
Dec 19, 2024 Contents Plexium's Mission Statement: To improve patient outcomes through innovative therapeutics. Vision Statement of Plexium: To be a leader in driving healthcare โฆSee details»
Who Owns Plexium โ CanvasBusinessModel.com
Dec 19, 2024 Plexium, a cutting-edge technology company revolutionizing the way we interact with data, has captured the attention of the tech world with its innovative products and โฆSee details»
Plexium, Inc. (Plexium, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ_ๆ โฆ
May 7, 2025 ไบ่งฃPlexium, Inc. (Plexium, Inc.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็38็ฏๆฐ้ปๅ1็ฏๆ็ฎ๏ผ็พ็ ้ขๅ:่ฟ็ค๏ผๅ ๅๆณไธไปฃ่ฐข็พ็ ๏ผๆๆฏๅนณๅฐ:้่งฃๅๅๅญ่ถ๏ผ่็ฝๆฐด โฆSee details»
Plexium - The Org
Plexium is a pharmaceutical company developing first-in-class therapeutics by modulating E3 ligases.See details»